Seppo W. Langer

Seppo W. Langer

Clinical Associate Professor

Member of:

  • Clinical Oncology


  1. 2022
  2. Published

    A convolutional neural network for total tumor segmentation in [64Cu]Cu-DOTATATE PET/CT of patients with neuroendocrine neoplasms

    Carlsen, E. A., Lindholm, Kristian, Hindsholm, A., Gæde, M., Ladefoged, C. N., Loft, M., Johnbeck, C. B., Langer, Seppo W., Oturai, P., Knigge, Ulrich, Kjær, Andreas & Andersen, Flemming Littrup, 2022, In: EJNMMI Research. 12, 1, p. 1-10 30.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Activity Dose Reduction in 64Cu-DOTATATE PET in Patients with Neuroendocrine Neoplasms: Impact on Image Quality and Lesion Detection Ability.

    Loft, M., Carlsen, Esben Andreas, Johnbeck, C. B., Jensen, C. V., Andersen, Flemming Littrup, Langer, Seppo W., Oturai, P., Knigge, Ulrich & Kjær, Andreas, 2022, In: Molecular Imaging and Biology. 24, p. 600–611

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Clinical features affecting efficacy of immune checkpoint inhibitors in pretreated patients with advanced NSCLC: a Danish nationwide real-world study

    Mouritzen, M. T., Junker, K. F., Carus, A., Ladekarl, M., Meldgaard, P., Nielsen, A. W. M., Livbjerg, A., Larsen, J. W., Skuladottir, H., Kristiansen, C., Wedervang, K., Schytte, T., Hansen, K. H., Østby, A-C., Frank, M. S., Lauritsen, J., Sørensen, J. B., Langer, S. W., Persson, G. F., Andersen, J. L. & 7 others, Homann, P. H., Kristensen, E. B., Drivsholm, L. B., Bøgsted, M., Christensen, H. S., Pøhl, M. & Bjørnhart, B., 2022, In: Acta Oncologica. 61, 4, p. 409-416

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    DLL3 expression and clinico-pathological data in 247 patients with NEN

    Clausen, Malene Martini, Federspiel, B., Carstensen, F., Suppli, M. H., Kjær, Andreas, Andreassen, Mikkel, Garbyal, Rajendra Singh, Knigge, Ulrich & Langer, Seppo W., 2022, In: Journal of Neuroendocrinology. 34, S1, p. 104 1 p.

    Research output: Contribution to journalConference abstract in journalResearch

  6. Published

    First-in-Human PET Imaging of Tissue Factor in Patients with Primary and Metastatic Cancers Using 18F-labeled Active-Site Inhibited Factor VII (18F-ASIS): Potential as Companion Diagnostic

    Loft, Mathias Hougaard, Christensen, C., Clausen, Malene Martini, Carlsen, Esben Andreas, Hansen, C. P., Kroman, Niels Thorndahl, Langer, Seppo W., Høgdall, Claus Kim, Madsen, J., Gillings, N., Nielsen, Carsten Haagen, Klausen, Thomas Levin, Holm, S., Loft, A., Berthelsen, A. K. & Kjær, Andreas, 2022, In: Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 63, 12, p. 1871-1879

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    Innate immune function during antineoplastic treatment is associated with 12-months survival in non-small cell lung cancer

    Ryssel, Heidi, Egebjerg, K., Nielsen, Susanne Dam, Lundgren, Jens, Pøhl, M., Langer, Seppo W., Kjær, Andreas, Ostrowski, Sisse Rye & Fischer, Barbara Malene Bjerregaard, 2022, In: Frontiers in Immunology. 13, p. 1-12 1024224.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    Long-term outcomes after video-assisted thoracoscopic surgery in pulmonary large-cell neuroendocrine carcinoma

    Soldath, Patrick, Binderup, Tina, Carstensen, F., Clausen, Malene Martini, Kjær, Andreas, Federspiel, B., Knigge, Ulrich, Langer, Seppo W. & Petersen, René Horsleben, 2022, In: Surgical Oncology. 41, 101728.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Patient-reported health-related quality of life from a randomized phase II trial comparing standard-dose with high-dose twice daily thoracic radiotherapy in limited stage small-cell lung cancer

    Killingberg, K. T., Halvorsen, T. O., Fløtten, Ø., Brustugun, O. T., Langer, Seppo W., Nyman, J., Hornslien, K., Madebo, T., Schytte, T., Risum, S., Tsakonas, G., Engleson, J. & Grønberg, B. H., 2022, In: Lung Cancer. 166, p. 49-57 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    Phase II study of everolimus and temozolomide as 1-line treatment in metastatic high-grade gastroenteropancreatic neuroendocrine neoplasms (NET G3 and NEC)

    Morken, S., Langer, Seppo W., Sundlov, A., Detlefsen, S., Krogh, M., Tabaksblat, E., Hjortland, G. O., Svensson, J. B., Assmus, J., Couvelard, A., Perren, A. & Sorbye, H., 2022, In: Journal of Neuroendocrinology. 34, S1, p. 181-181 1 p.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  11. Published

    Prospective phase II trial of prognostication by 68Ga-NOTA-AE105 uPAR PET in patients with neuroendocrine neoplasms: Implications for uPAR targeted therapy

    Carlsen, Esben Andreas, Loft, Mathias Hougaard, Loft, A., Berthelsen, A. K., Langer, Seppo W., Knigge, Ulrich & Kjær, Andreas, 2022, In: Journal of Nuclear Medicine. 63, 9, p. 1371-1377

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1 2 Next

ID: 33841728